Asia-Pacific Label Free Detection Market was worth USD 0.25 billion in 2018 and estimated to be growing at a CAGR of 13.13%, to reach USD 0.47 billion by 2023 Since the discovery of drugs, label-free technologies have been used for the detecting as well as characterising molecular interactions. Over the years the use of label-free methods from primary screening through to mechanism-of-action studies in lead optimisation have only been hastened by the implementation of automated systems, increased sensitivity and the development of modern technologies. The progress made by the label free detection market can be seen not only through the sales figures that speak for themselves, but they have also ushered in a new era of drug development.
The most noteworthy features of Label Free Detection involve scientists being able to study primary cell types along with the endogenous receptors in cell lines. Both grant access to receptors in several natural states. The data gathered from Label Free Detection technologies is albeit a bit complex but provides a better reflection of the target biology. Recent advances in the label free instruments industry offer improved cost, efficiency, higher levels of sensitivity as well as sophisticated data analysis.
Recent advances in label-free instruments offer improved cost, throughput, increased sensitivity and more sophisticated data analysis. Since the need for labels is no longer there as the name suggests, there is no need for genetic manipulation of cells. This ensures that the response recorded by the researcher is as authentic as it can get as the cell’s physiological activity is uncontaminated. The use of label-free detection in a multimodal reader offers the researcher complete flexibility with biochemical and cellular analysis. The effects of drugs as measured in classical HTS formats can be directly compared in the same instrument and on the same cells, thereby allowing for the first-time direct comparisons to be made of drug pharmacology. As for the constraints of using label free technologies, it is a known fact that the technology is relatively new and still in its preliminary stages. The deconvolution of the high content data is another added challenge that is faced by the industry.
The Asia-Pacific Label Free Detection market is broadly classified into Consumables (Biosensor Chips and Microplates) and Instruments based on product type. Furthermore, based on application they are classified into Binding Kinetics, Binding Thermodynamics, Endogenous Receptor Detection, Hit Confirmation and Lead Generation. Based on technology used, they are classified into Bio-layer Interferometry(BLI), Cellular Dielectric Spectroscopy, Optical Waveguide Grating Technology(OWG) and Surface Plasmon Resonance(SPR). Based on geography, the Asia-Pacific region is divided into China, Japan, India, South Korea, Australia and Rest of APAC. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. In addition to the high CAGR, the region also has the third highest market share following closely behind Europe with North America leading the pack.
Some of the major companies dominating the market, by their products and services include Ametek, Inc., Bio-Rad Laboratories, Inc., BiOptix, Corning, Inc., Danaher Corporation, General Electric Corporation, Pall Corporation, PerkinElmer, all based in U.S but operating in the Asia-Pacific region as well. Attana AB from Sweden as well as Roche based in Switzerland are two European companies that have operations in the Asia-Pacific region.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Technology
5.1.1 Introduction
5.1.2 Bio-layer interferometry
5.1.3 Cellular Dielectric Spectroscopy
5.1.4 Optical Waveguide Grating Technology
5.1.5 Surface Plasmon Resonance
5.1.6 Y-o-Y Growth Analysis, By Technology
5.1.7 Market Attractiveness Analysis, By Technology
5.1.8 Market Share Analysis, By Technology
5.2 Type
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Binding Kinetics
5.3.3 Binding Thermodynamics
5.3.4 Endogenous Receptor Detection
5.3.5 Hit Confirmation
5.3.6 Lead Generation
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Type
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Ametek
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories
8.3 BiOptix
8.4 Corning
8.5 Danaher
8.6 General Electric Corporation
8.7 Pall Corporation
8.8 PerkinElmer
8.9 Attana AB
8.10 Roche
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
